Engineering CpG-Free ITR for AAV Gene Therapy

被引:0
|
作者
Pan, Xiufang [1 ]
Yue, Yongping [1 ]
Wasala, Lakmini [1 ]
Zhang, Keqing [1 ]
Duan, Dongsheng [1 ,2 ,3 ,4 ]
机构
[1] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA
[2] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO USA
[3] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO USA
[4] Univ Missouri, Coll Engn, Dept Biomed Biol & Chem Engn, Columbia, MO USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
516
引用
收藏
页码:227 / 227
页数:1
相关论文
共 50 条
  • [31] AAV gene therapy for Dravet Syndrome
    Diaz, Juan Antinao
    Counsell, John
    Morris, Gareth
    Buckley, Suzanne
    Davidge, Joanna
    Schorge, Stephanie
    Waddington, Simon
    Karda, Rajvinder
    HUMAN GENE THERAPY, 2018, 29 (07) : A9 - A9
  • [32] Immunogenicity and toxicity of AAV gene therapy
    Ertl, Hildegund C. J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] AAV gene therapy vectors in the TMJ
    Brouxhon, Sabine M.
    O'Banion, Michael Kerry
    Kyrkanides, Stephanos
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2022, 8 (06): : 1561 - 1566
  • [34] Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR
    D'Costa, Susan
    Blouin, Veronique
    Broucque, Frederic
    Penaud-Budloo, Magalie
    Francois, Achille
    Perez, Irene C.
    Le Bec, Christine
    Moullier, Philippe
    Snyder, Richard O.
    Ayuso, Eduard
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16019
  • [35] Safety questions for AAV gene therapy
    Charles P. Venditti
    Nature Biotechnology, 2021, 39 : 24 - 26
  • [36] Lyophilisation of AAV Gene Therapy Product
    Bendik, Marian
    MOLECULAR THERAPY, 2018, 26 (05) : 188 - 189
  • [37] Safety questions for AAV gene therapy
    Venditti, Charles P.
    NATURE BIOTECHNOLOGY, 2021, 39 (01) : 24 - 26
  • [38] Neutralizing the Neutralizers in AAV Gene Therapy
    Herzog, Roland W.
    Biswas, Moanaro
    MOLECULAR THERAPY, 2020, 28 (08) : 1741 - 1742
  • [39] Effect of CpG Depletion on Anti-Capsid CD8+T Cell Priming to AAV Gene Therapy
    Bertolini, Thais
    Shirley, Jamie
    Zolotukhin, Irene
    Kumar, Sandeep
    Herzog, Roland
    MOLECULAR THERAPY, 2020, 28 (04) : 22 - 23
  • [40] DNA METHYLATION OF SPECIFIC CPG SITES IN THE MMP-13 PROMOTER REDUCES ITS ACTIVITY IN HUMAN CHONDROCYTES: LUCIFERASE ASSAY WITH CPG-FREE REPORTER VECTOR
    Hashimoto, K.
    Otero, M.
    Roach, H. I.
    Goldring, M. B.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S171 - S171